Key result
Community blood pressure screening in Cameroon identifies ~21% hypertension prevalence, with low awareness and treatment rates.
Why the study?
Hypertension awareness, treatment, and control rates remain low globally, necessitating opportunistic screening to identify individuals with raised blood pressure.
Cross-Sectional (n=8,883)
Yes
The May Measurement Month 2018 campaign in Cameroon identified a 21.0% hypertension prevalence, with low awareness (34.5%) and treatment (27.2%) rates, highlighting the value of opportunistic screening programs.
Reveals substantial gaps in hypertension awareness and treatment; leaves open whether screening campaigns improve population outcomes.
Hypertension is a global public health challenge, but awareness, treatment, and control rates remain low. May Measurement Month (MMM) creates a platform for awareness creation and opportunistic screening which can identify significant numbers with raised blood pressure (BP). We present results of the 2018 edition of MMM in Cameroon. A cross-sectional survey of self-selected volunteers aged ≥18 years was conducted in May 2018. The definition of hypertension and statistical analyses followed the standard protocol. Data were collected from 28 public (indoors and outdoors) and private locations which were assigned unique site identification numbers, over a 30-day period. Of the 8883 participants screened, 53.8% were male and the median age was 35 (interquartile range 21) years, and 30.0% reported not having a previous BP measurement. After imputation, 1867 (21.0%) were hypertensive, 645 (34.5%) were aware of their diagnosis, and 507 (27.2%) were on antihypertensive medication, among whom 242 (47.8%) had controlled BP. In linear regression models adjusting for age, sex, and the use of antihypertensive medication, systolic and diastolic BP were significantly higher in participants aware of their diagnosis, those on antihypertensive medication, and who reported alcohol intake of 1-3 times per month and, one or more times per week. Hypertension prevalence is the lowest, and awareness, treatments, and control rates the highest reported in epidemiological studies in Cameroon in the last two decades. Further surveys will be useful in evaluating the impact, if any, of the MMM campaign on the burden of hypertension in the Cameroon.
No takes yet. Share an insight, caveat, or question.
Dzudié et al. (2020) conducted a cross-sectional in Hypertension (n=8,883). Blood pressure screening was evaluated on Hypertension prevalence. Blood pressure screening of 8,883 volunteers in Cameroon identified a hypertension prevalence of 21.0%, with 34.5% aware of their diagnosis and 27.2% on antihypertensive medication.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: